Stockholm, September 20, 2024 - Intervacc AB (publ) predicts that the vaccine Strangvac®, which is approved for sale in Europe and the UK, may be out-of-stock for a short period from the 1st October 2024. The ... Read more
Stockholm, September 20, 2024 – Intervacc AB (publ) announces that the application for supplementary protection for Strangvac®, an innovative vaccine against strangles, has now been approved in the United ... Read more
The Group in summary
Read moreStockholm, August 15, 2024 –Intervacc AB (publ) and the Karolinska Institute, KI, announce that they have extended their collaboration to develop a new generation of animal health vaccines using recombinant fusion ... Read more
Stockholm, July 31, 2024 - Intervacc AB (publ) announces that the reduction of share capital and nominal value, decided by the Annual General Meeting on May 15, 2024, has been registered by the Swedish Companies ... Read more
Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 15 May 2024, at which the following resolutions were made.